Triggering receptor expressed on myeloid cells 2 (TREM2) was first discovered because variants affect the risk of developing late-onset Alzheimer’s disease (AD).
Keeping you up to date on recent developments in diagnostics, including: GEP tests poor predictors of melanoma recurrence; A nonfasting blood test for diabetes; Starving out Chlamydia.
Keeping you up to date on recent developments in orthopedics, including: Long-term risks of joint implants; New approach to treating osteoarthritis advances; Osmotic therapy device reduces swelling to prevent secondary injuries in rats.
Keeping you up to date on recent developments in oncology, including: Novel nanoparticle releases therapy via DNA sequence trigger; In AML, collapse prevents relapse; The next great nano-thing: nanopaper.
Investigators have developed a new approach to classifying neurodegenerative disorders that used the overall patterns of protein aggregation, rather than specific proteins, to define six clusters of patients that crossed traditional diagnostic categories.
Keeping you up to date on recent developments in cardiology, including: Mutation could hint at heart disease therapeutic target; Nanoparticle system captures heart-disease biomarker; Helping predict chest pain in those with heart disease.
Investigators at Weill Cornell Medical College have demonstrated that mitochondrial DNA drives the abscopal antitumor response to radiation, which can be boosted by autophagy inhibition.
Keeping you up to date on recent developments in neurology, including: Brain computer improves function in paralyzed patient; Blood test could diagnose brain damage hours after birth; Power-saving, wireless neural implant developed; After injury, astrocytes can make interneurons.
BioWorld looks at translational medicine, including: PRC member affects blood formation during aging; Localized bile acid improves systemic blood glucose control; After injury, astrocytes can make interneurons; In AML, collapse prevents relapse; Starving out Chlamydia.
RSS
